GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand

Linda Yang, Chih-Chuan Chang, Zhe Sun, Dennis Madsen(Novo Nordisk (Denmark)), Haisun Zhu, Søren Berg Padkjær(Novo Nordisk (Denmark)), Xiaoai Wu, Tao Huang, Karin Hultman(Novo Nordisk (Denmark)), Sarah Juel Paulsen(Novo Nordisk (Denmark)), Jishu Wang, Anne Bugge(Novo Nordisk (Denmark)), Jane Boesen Frantzen(Novo Nordisk (Denmark)), Per Nørgaard(Novo Nordisk (Denmark)), Jacob Jeppesen(Novo Nordisk (Denmark)), Zhiru Yang, Anna Secher(Novo Nordisk (Denmark)), Haibin Chen, Xun Li, Linu M. John(Novo Nordisk (Denmark)), Bing Shan, Zhenhua He, Xiang Gao, Jing Su, Kristian T. Hansen(Novo Nordisk (Denmark)), Wei Yang, Sebastian B. Jørgensen(Novo Nordisk (Denmark))
Nature Medicine
August 28, 2017
Cited by 648

Abstract


Related Papers